Correlation Between Vaxart and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaxart and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and Silo Pharma, you can compare the effects of market volatilities on Vaxart and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and Silo Pharma.

Diversification Opportunities for Vaxart and Silo Pharma

VaxartSiloDiversified AwayVaxartSiloDiversified Away100%
0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vaxart and Silo is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Vaxart i.e., Vaxart and Silo Pharma go up and down completely randomly.

Pair Corralation between Vaxart and Silo Pharma

Given the investment horizon of 90 days Vaxart Inc is expected to generate 1.0 times more return on investment than Silo Pharma. However, Vaxart Inc is 1.0 times less risky than Silo Pharma. It trades about 0.04 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.0 per unit of risk. If you would invest  81.00  in Vaxart Inc on October 6, 2024 and sell it today you would earn a total of  3.00  from holding Vaxart Inc or generate 3.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vaxart Inc  vs.  Silo Pharma

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -30-20-100102030
JavaScript chart by amCharts 3.21.15VXRT SILO
       Timeline  
Vaxart Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxart Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Vaxart may actually be approaching a critical reversion point that can send shares even higher in February 2025.
JavaScript chart by amCharts 3.21.15NovDecJanDecJan0.550.60.650.70.750.80.85
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15NovDecJanDecJan0.80.911.11.21.3

Vaxart and Silo Pharma Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-16.48-12.34-8.21-4.070.04.078.2712.4816.6820.89 0.0110.0120.0130.014
JavaScript chart by amCharts 3.21.15VXRT SILO
       Returns  

Pair Trading with Vaxart and Silo Pharma

The main advantage of trading using opposite Vaxart and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Vaxart Inc and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios